Experience

BioNTech Announces Global Collaboration Agreement With Bristol Myers Squibb

June 3, 2025

Cooley advised BioNTech SE, a global biotechnology company pioneering next-generation immunotherapies, on its global co-development and co-commercialization collaboration agreement with Bristol Myers Squibb for BioNTech’s antibody candidate BNT327. The transaction includes a $1.5 billion upfront payment and $2 billion total in noncontingent anniversary payments through 2028.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
J. Brian Stalter
Special Counsel, New York
John Forrest
Associate, Boston
Arda Can Tekin
Associate, New York
Megan Browdie
Partner, Washington, DC
David Burns
Special Counsel, Washington, DC
Jonas Koponen
Partner, Brussels
Rachel Thorn
Of counsel, New York
Eric Blanchard
Partner, Boston
Christopher Kimball
Partner, Washington, DC
Joe Sandys
Special Counsel, London
Natasha Leskovsek
Of Counsel, Washington, DC
Navya Dasari
Associate, New York
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Advanced Instruments Acquires and Merges With Nova Biomedical

March 19, 2025

Cooley advised Advanced Instruments, a subsidiary of Patricia Industries and a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, on intellectual property and licensing aspects in connection with its definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology therapeutics.

Read more

Related contacts

Joanna Liebes Hubberts
Partner, San Diego
Charity Williams
Partner, San Diego
Mika Reiner Mayer
Partner, Palo Alto
Lisa Amii
Patent Agent, Palo Alto
Michael Fernando
Associate, London
Gayana Stokes
Senior Paralegal, Washington, DC
John Paul Oleksiuk
Partner, New York
Colleen R. Wellington-Caban
Associate, Washington, DC
Leanne Andrepont
Senior Trademark Paralegal
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Cooley Secures Win for Liquidia to Launch First Product

April 5, 2024

Cooley successfully lifted a Hatch-Waxman injunction for Liquidia Technologies, a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products, enabling Liquidia to launch its new drug, Yutrepia.

Read more

Related contacts

Sanya Sukduang
Partner, Washington, DC
Jonathan Davies
Partner, Washington, DC
Daniel Knauss
Partner, Palo Alto
Adam Pivovar
Partner, Washington, DC
Robert Minn
Associate, Palo Alto
Lauren Strosnick
Associate, Palo Alto
Jennifer Volk-Fortier
Associate, Washington, DC
Sam Whitt
Associate, Washington, DC
Larissa Diaz
Senior Paralegal, Washington, DC
Jeannine Douglas
Paralegal Specialist, Palo Alto
Melissa Eskola
Paralegal Specialist, Reston
Loreylys Feliciano
Paralegal Specialist, Chicago
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Adaptive Phage Therapeutics Enters Into Definitive Merger Agreement With BiomX

March 6, 2024

Cooley advised Adaptive Phage Therapeutics, a US-based, privately held, clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections, on its definitive merger agreement with BiomX, a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria.

Read more

Related contacts

Christian Plaza
Partner, Reston
Brian Leaf
Partner, Reston
Matthew Schwee
Partner, Reston
John Lavoie
Partner in Charge – Reston, Reston
Kenneth Krisko
Partner, Reston
Eileen Marshall
Partner, Washington, DC
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Adrienne Beaudoin Deshmukh
Associate, Reston
Rick Jantz
Associate, Santa Monica
Anne Luquette
Associate, San Francisco
Tyler Saavedra-Buckley
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Douglas Lyles
Senior Research Services & Access Analyst

Jackpocket Reaches Agreement to Be Acquired by DraftKings for $750 Million

February 15, 2024

Cooley advised Jackpocket, the first licensed third-party lottery courier app in the US, on its definitive agreement to be acquired by DraftKings for $750 million.

Read more

Related contacts

Kevin Cooper
Partner, New York
Jeff Laretto
Partner, New York
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Brendan Hughes
Partner, Washington, DC
Len Jacoby
Partner, New York
Phil Mitchell
Partner, New York
Timothy Shapiro
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stacey A. Bradford
Special Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Ryan Montgomery
Partner, Boston
Judd Lauter
Special Counsel, San Francisco
Steve Andersen
Associate, New York
Cara Buchicchio
Associate, New York
David Dalton
Associate, Santa Monica
Erika Freeman
Associate, New York
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Alexandra Leavy
Associate, New York
Anisha Mohin
Associate, New York
Pat O'Connell
Associate, New York
Scott D. Rudin
Associate, New York
Yoon Soo (Peter) Shin
Associate, New York
Steven A. Zuckerman
Associate, New York
Margie Murphy
Paralegal Specialist, New York
Patricia Myers
Paralegal Specialist, Colorado
Douglas Lyles
Senior Research Services & Access Analyst
Shaun (Tianjie) Wang
Associate, New York

Related Practices & Industries

View more